News
04.01.2023
PMA Insights: Week 1

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Case Studies
01.01.2023
Rapid pricing and market access assessment

Our client needed a rapid pricing and market access (P&MA) assessment across the US and EU5 in sever...

Read more
Case Studies
01.01.2023
Enhancing Managed Entry Agreements (MEA)

Our client wanted to develop a training programme to help their employees learn about the value of M...

Read more
Case Studies
01.01.2023
Raising awareness of the EU market access

Development of an EU pricing and market access e-Learning training resource to provide awareness of ...

Read more
Case Studies
01.01.2023
Developing real-world evidence (RWE) capabilities

Development and delivery of training covering the fundamental principles of RWE, including defining ...

Read more
Case Studies
01.01.2023
Developing a tender strategy for a rare disease

The company found themselves facing competitive tenders for the first time in this disease space - t...

Read more
Case Studies
01.01.2023
Securing reimbursement for an orphan drug via NICE

Our client was seeking NICE approval for their ultra-orphan drug in an indication that was not well ...

Read more
Case Studies
01.01.2023
Developing scenario-based commercial assessments

Identification of current cost of oncology care treatment options.

Read more
Case Studies
01.01.2023
Development of EU country level biosimilar pricing

Development of local market access plans that could be used by EU affiliates, who had not previously...

Read more
Case Studies
01.01.2023
Development of an EU P&R strategy

Our client needed to understand the clinical and economic evidence requirements that drive payer dec...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.